COVID-19 Updates
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.
Feature
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.
News
Even mild COVID is hard on the brain
New study results suggest a severe pattern of changes in how the brain communicates as well as its structure in people with anxiety and depression...
From the Journals
Celiac disease appears to double COVID-19 hospitalization risk
“To our knowledge this is the first study that demonstrated a vaccination effect on mitigation of the risk of hospitalization in celiac disease...
Conference Coverage
Prone positioning curbs need for intubation in nonintubated COVID-19 patients
The use of so-called “awake prone positioning” has been common since the early days of the COVID-19 pandemic.
From the Journals
COVID vs. flu: Which is deadlier?
People who were hospitalized with Omicron COVID-19 infections were 54% more likely to die, compared with people who were hospitalized with the flu...
From the Journals
COVID infection provides immunity equal to vaccination: Study
But protection against the BA.1 subvariant of Omicron was not as high.
From the Journals
Untreated COVID often involves relapse, clarifying antiviral rebound discussion
A new study’s findings offer a natural history of COVID-19 that will inform discussions and research concerning anti-viral therapy.
Commentary
What’s new in brain health?
A new study shows that nonmedical treatment is effective in people with frequent episodic and chronic tension-type headache.
From the Journals
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...